Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|22 Sep 2011||Submitted||Original manuscript|
|17 Oct 2011||Reviewed||Reviewer Report - Gillian Smith|
|31 Oct 2011||Reviewed||Reviewer Report - Peter Wilson|
|31 Oct 2011||Reviewed||Reviewer Report - Andrea Sartore Bianchi|
|7 Mar 2012||Author responded||Author comments - Leonie Mekenkamp|
|Resubmission - Version 2|
|7 Mar 2012||Submitted||Manuscript version 2|
|17 Mar 2012||Reviewed||Reviewer Report - Gillian Smith|
|26 Mar 2012||Reviewed||Reviewer Report - Peter Wilson|
|27 Mar 2012||Reviewed||Reviewer Report - Andrea Sartore Bianchi|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|26 Jun 2012||Editorially accepted|
|17 Jul 2012||Article published||10.1186/1471-2407-12-292|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.